Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.

Ming-Ju Huang | Wei Zhang | Qi Wang | Zhi-Jun Yang | Sheng-Bin Liao | Li Li
Journal of ovarian research | 2018

Whether there is a mechanistic link between FOLR1 and response to cisplatin has not been extensively examined. In this study, we determine the expression of FOLR1 in ovarian cancer and examine if FOLR1 levels influence response to cisplatin.

Pubmed ID: 29433550

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Guangxi Natural Science Foundation and the Ministry of Education Special Fund for Ph.D. Programs (Grant no. 20134503110009 ),
    Id: Grant no. 20134503110009 and Grant no. 2014jjAA40637

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


SK-OV-3 (tool)

RRID:CVCL_0532

Cell line SK-OV-3 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions